Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP2151 Phase 1 Multiple Oral Dosing in Healthy Japanese Men
NCT02796118Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2006
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Amenamevir in herpes zoster (HZ) (6 arms), sponsored by Astellas Pharma. Primary endpoints: Maximum Plasma Concentration at Day 7, Time to Maximum Plasma Concentration at Day 7 and 11 more. Started Jul 2006; status: completed.
02
Drugs
Amenamevir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02796118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796118.